Abstract Background Sulfadoxine-pyrimethamine (SP). as a partner to artesunate as ACT is the treatment of choice for uncomplicated P. falciparum infections in the majority of India and SP-resistance has a potential to lead to ACT failure. In the lack of robust surveillance of therapeutic efficacy of SP. https://www.roneverhart.com/Roosevelt/